share_log

AbbVie | 4: Statement of changes in beneficial ownership of securities-Officer RICHMOND TIMOTHY J.

SEC announcement ·  Mar 5 17:34
Summary by Moomoo AI
On March 1, 2024, Timothy J. Richmond, EVP and Chief HR Officer of AbbVie Inc. (ABBV), completed a series of transactions involving the company's common stock. Richmond acquired 45,700 shares through the exercise of derivative securities at a price of $61.36 per share. Subsequently, he sold a total of 75,680 shares in multiple open market transactions at prices ranging from $176.35 to $177.71, resulting in a total market value of $13,415,503. After these transactions, Richmond's direct holdings in AbbVie common stock amounted to 13,837 shares.
On March 1, 2024, Timothy J. Richmond, EVP and Chief HR Officer of AbbVie Inc. (ABBV), completed a series of transactions involving the company's common stock. Richmond acquired 45,700 shares through the exercise of derivative securities at a price of $61.36 per share. Subsequently, he sold a total of 75,680 shares in multiple open market transactions at prices ranging from $176.35 to $177.71, resulting in a total market value of $13,415,503. After these transactions, Richmond's direct holdings in AbbVie common stock amounted to 13,837 shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more